In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

New collaboration empowers customers with sequence-perfect constructs as long as50 kb Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, ...

VIENNA--(BUSINESS WIRE)--Ribbon Bio GmbH, the DNA synthesis company, today announced the launch of MiroSynth™ DNA, its first commercial product designed to meet the growing demand for complex and ...

Atlas Data Storage and imec have entered into a new strategic partnership aimed at accelerating the development of DNA‑based digital storage technologies.

- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...

Google's new AI tool can read DNA like a language, and see immediately if a word substitution will change the meaning of that sentence, the company says. — © AFP ...

imec, a global leader in nanoelectronics and digital innovation, and Atlas Data Storage, a pioneer of production-scale DNA data storage, today announce a new strategic partnership to accelerate the ...

Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

Biotech investments fuel DNA manufacturing in Asia-Pacific. The global DNA manufacturing market is projected to reach $21.82b ...